Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Tavendale, S. Mukhopadhyay, J. Sypek, M. Fleming, D. Macgregor, S. Goldman, C. Williams, D. Miller, C. Palmer (Dundee, Brighton, United Kingdom; Cambridge, Collegeville, United States Of America). Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma. Eur Respir J 2010; 36: Suppl. 54, 4309

Member's Comments

No comment yet.

Related content which might interest you: Matrix metalloproteinase (MMP) 12 is not associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients Source: Eur Respir J 2005; 25: 885-890 Year: 2005 Expression of matrix metalloproteinases and TIMP inhibitors in circulation/lung in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Matrix metalloproteinases and lung disease severity in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Role of matrix metalloproteinase in predicting of COPD stability Source: International Congress 2015 – COPD: notable points Year: 2015 Matrix Metalloproteinases (MMPs) in patients with pulmonary tuberculosis (PT) and comorbid COPD Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Matrix metalloproteinase 2 expression in distal lung of fatal asthma Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006 Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Relationship between circulating serpina 3g, activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, 2 with chronic obstructive pulmonary disease severity Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Matrix metalloproteinase, hyaluronic acid and C-reactive protein: Are they really markers of lung obstruction at COPD but not cardiovascular comorbidity? Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Matrix metalloproteinases in COPD Source: Eur Respir J 2011; 39: 197-209 Year: 2012 Matrix metalloproteinases in COPD Source: Eur Respir J 2012; 39: 197-209 Year: 2012 Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space Source: Eur Respir J 2008; 32: 644-650 Year: 2008 Could concentration of matrix metalloproteinase-9 in serum of COPD patients change into the basic disease progress and a degree of airway obstruction? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006 Correlation of serum Matrix metalloproteinase-9 and clinico-functional parameters in COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Genes of detoxication system, matrix metalloproteinase 9 (MMP9) and set of group factors of blood in the risk of development of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 63s Year: 2004 Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007 Matrix metalloproteinase levels of bronchial mucosa and the correlation with clinical parameters in clinically stable bronchiectasis Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015